A study analyses the best technique to prevent bleeding during myomectomy

A study analyses the best technique to prevent bleeding during myomectomy

A study analyses the best technique to prevent bleeding during myomectomy

At Dexeus Mujer, two techniques are routinely applied to maintain haemostasis: temporary clipping of both uterine arteries at their origin and of the ovarian vessels at the pelvic infundibulum, and intramyometrial epinephrine injection before performing the hysterectomy. Both procedures are safe and lead to complications only in a small number of cases. owever, epinephrine injection is associated with side effects such as hypertension, bradycardia, arrhythmia and cardiac arrest. Clipping is an alternative, but until this study it was not known whether the rate of haemorrhagic complications could be similar, and it is a less widespread option because it requires experience in its application.

In total, 625 patients who underwent surgery between January 2009 and December 2019 were analysed for this study. Their mean age was 37.82 years and 69.8 % had symptoms. The most common symptoms were bleeding (33.2 %), increased pelvic volume (24.2 %) and fertility problems (24 %).

The authors of the study concluded that temporary clipping of both uterine arteries at their origin and of the ovarian vessels is the best technique to reduce the risk of bleeding during surgery, although it is not a widespread procedure, as it requires experience in the application of this technique. They also concluded that laparoscopic myomectomy is a safe technique, which in general offers great surgical and subsequent reproductive success. However, they admit that their study has several limitations, as it is a single-centre study, mainly descriptive, and based on their own experience. Therefore, they point out that further studies are needed to reach definitive conclusions.

Reference study:
Evolution of laparoscopic myomectomy and description of two hemostatic techniques in a large teaching gynecological center
Sandra Coll, Silvia Feliu, Claudia Montero, Maria Pellisé-Tintoré, Francesc Tresserra, Ignacio Rodríguez, Pere Nolasc Barri-Soldevila.
Eur J Obstet Gynecol Reprod Biol. 2021 Aug 26;265:181-189. doi: 10.1016/j.ejogrb.2021.08.023..

How can we help you?

We inform you that the personal data that you provide by filling in this form will be treated by Dexeus Mujer Foundation as responsible for this website. The purpose of collecting and processing this data is to contact you regarding your request and in the event that you expressly authorize us to send you information on activities, promotions and / or services and our periodic newsletter. The legitimation is carried out through the consent of the interested party. You can exercise your rights of access, rectification, limitation and delete the data before the data protection officer at dpd@dexeus.com as well as the right to file a claim with a control authority. You can consult the additional and detailed information on Data Protection in our privacy policy.

¿Cómo podemos ayudarte?

Te informamos que los datos de carácter personal que proporciones rellenando el presente formulario serán tratados por Fundación Dexeus Mujer como responsable de esta web. La finalidad de la recogida y tratamiento de estos datos es contactar contigo en referencia a tu solicitud y en caso de que expresamente nos autorices enviarte información sobre actividades, promociones y/o servicios y nuestro boletín informativo periódico. La legitimación se realiza a través del consentimiento del interesado. Podrás ejercer tus derechos de acceso, rectificación, limitación y suprimir los datos ante el delegado de protección de datos en dpd@dexeus.com así como el derecho a presentar una reclamación ante una autoridad de control. Puedes consultar la información adicional y detallada sobre Protección de Datos en nuestra política de privacidad.